PureTech is a leading brand that is dedicated to giving life to new classes of medicine in order to positively impact the lives of patients suffering from devastating diseases. With a strong focus on scientific innovation and a track record of clinical success, PureTech has outperformed the biopharma industry average by 6x. Their research and development efforts have generated numerous therapeutics and therapeutic candidates, all aimed at addressing a wide range of clinical indications.

PureTech's approach involves enhancing on-target efficacy, enabling oral administration, and improving tolerability to unlock new classes of medicine. This has resulted in a pipeline of promising product candidates that are soon to be filed for FDA approval. The company's seasoned senior leadership team brings extensive experience, having overseen the R&D of therapeutics supporting 27 regulatory approvals and played key roles in companies acquired for over $14B.

Furthermore, PureTech's network of scientific collaborators allows them to identify and co-invent cutting-edge intellectual property, providing them with a competitive advantage. Stay updated with PureTech's progress through their news and press releases, which highlight their achievements and milestones. For any clinical trial inquiries or general information, feel free to reach out to their dedicated teams.

PureTech Health is at the forefront of transforming healthcare and shaping the future of medicine